NanoVibronix Inc (NASDAQ:NAOV) shares are trading sharply higher on Monday after the company announced a new U.S. patent granted to its wholly-owned subsidiary, ENvue Medical Holdings.
What To Know: The U.S. Patent and Trademark Office issued U.S. Patent No. 12,409,105 B2, titled “Insertion Device Positioning Guidance System and Method.” The patent covers proprietary systems for guiding the insertion of medical devices, such as feeding tubes, using electromagnetic positioning technology.
The company says this patent aims to improve real-time visualization and accuracy, reducing the risk of misplacement and associated complications for safer and more efficient procedures.
Dr. Doron Besser, CEO of NanoVibronix, called the patent a “significant milestone”. “We are continuing to build a robust and growing IP portfolio that not only protects our proprietary technology but also creates strong barriers to entry in our target markets,” he stated.
Benzinga Edge Rankings: Benzinga Edge delivers real-time stock alerts, trade ideas and professional investing tools to help you profit in any market.
Price Action: According to data from Benzinga Pro, NAOV shares are trading higher by 61.95% to $10.51 Monday afternoon. The stock has a 52-week high of $162.50 and a 52-week low of $4.71.
Read Also: AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit
How To Buy NAOV Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in NanoVibronix’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock
